6min chapter

Blood Cancer Talks cover image

Episode 27. Management of PNH

Blood Cancer Talks

CHAPTER

Factor B and Factor D Inhibitors: What You Need to Know

The risk of transformation of P.N.H. to M.B.S. is small, and it's mainly from the bone marrow failure. Patients with immune-mediated aplastic anemia have 15 to 20% chance of developing M.D. in 10 years. The best candidates for this will be patients who are on C5 inhibitors whose manifestations are primarily homolysis. And I think you'll see a lot more data on clotting phenotype on these drugs before they're blocked.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode